Search hospitals
>
California
>
Los Angeles
University of Southern California
Claim this profile
Los Angeles, California 90033
Global Leader in Cancer
Global Leader in Alzheimer's Disease
Conducts research for HIV Infection
Conducts research for Lung Cancer
Conducts research for Pancreatic Cancer
660 reported clinical trials
61 medical researchers
Summary
University of Southern California is a medical facility located in Los Angeles, California. This center is recognized for care of Cancer, Alzheimer's Disease, HIV Infection, Lung Cancer, Pancreatic Cancer and other specialties. University of Southern California is involved with conducting 660 clinical trials across 845 conditions. There are 61 research doctors associated with this hospital, such as Anthony El-Khoueiry, MD, Heinz-Josef Lenz, Jacob Thomas, MD, and Jorge J. Nieva.
Area of expertise
Cancer
University of Southern California has run 38 trials for Cancer. Some of their research focus areas include:
Alzheimer's Disease
University of Southern California has run 32 trials for Alzheimer's Disease. Some of their research focus areas include:
Top PIs
Anthony El-Khoueiry, MD
USC Norris Comprehensive Cancer Center
2 years of reported clinical research
Heinz-Josef Lenz
USC / Norris Comprehensive Cancer Center
8 years of reported clinical research
Jacob Thomas, MD
USC Norris Comprehensive Cancer Center
2 years of reported clinical research
Jorge J. Nieva
USC / Norris Comprehensive Cancer Center
6 years of reported clinical research
Clinical Trials running at University of Southern California
Breast Cancer
Lung Cancer
Colorectal Cancer
Cervical Cancer
Cancer
Esophageal Cancer
Squamous Cell Carcinoma
Pancreatic Cancer
Prostate Cancer
Brain Tumor
NX-1607
for Advanced Cancer
This trial is testing NX-1607, a new experimental drug, in adults with advanced cancers that don't respond to standard treatments. The goal is to see if NX-1607 can safely stop or reduce cancer growth, either by itself or with another drug called paclitaxel. Paclitaxel is a widely used anti-cancer drug for treating various types of solid malignant tumors including breast, ovarian, and lung cancers.
Recruiting
1 award
Phase 1
MT-4561
for Cancer
This is a First In Human (FIH), multicenter, open-label, Phase I/II study to evaluate safety, tolerability, Pharmacokinetics (PK), pharmacodynamics, and efficacy of MT-4561 in patients with advanced solid tumors. This study will be conducted in 3 parts. Part 1 is aimed at evaluating safety, tolerability, PK and pharmacodynamics of MT-4561 and determining the Maximum Tolerated Dose (MTD) using the Bayesian Optimal Interval (BOIN) design. The study details and doses of Part 2 (dose-optimization) and Part 3 (Drug-Drug Interaction) will be available after review of applicable Part 1 results.
Recruiting
1 award
Phase 1 & 2
5 criteria
DF1001
for Solid Cancers
This trial is testing a new treatment called DF1001-001 that helps the immune system target and destroy cancer cells. It focuses on patients with certain types of cancers that have a protein called HER2. The treatment works by activating immune cells to recognize and attack these cancer cells.
Recruiting
1 award
Phase 1 & 2
52 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at University of Southern California?
University of Southern California is a medical facility located in Los Angeles, California. This center is recognized for care of Cancer, Alzheimer's Disease, HIV Infection, Lung Cancer, Pancreatic Cancer and other specialties. University of Southern California is involved with conducting 660 clinical trials across 845 conditions. There are 61 research doctors associated with this hospital, such as Anthony El-Khoueiry, MD, Heinz-Josef Lenz, Jacob Thomas, MD, and Jorge J. Nieva.
Where is University of Southern California located?
The University of Southern California (USC) Hospital, situated at 1500 San Pablo St, Los Angeles, California, is a key component of the Keck Medical Center of USC, encompassing both the Keck Hospital of USC and the USC Norris Cancer Hospital. It provides a wide range of services including dermatology, clinical nutrition, breast cancer care, and critical care medicine. Parking options include the Keck parking structure accessible from San Pablo Street, metered parking on Jefferson Boulevard, and the Jefferson Boulevard Parking Structure offering a $14 daily fee.
Who should I call to ask about financial aid or insurance network?
**University of Southern California (USC) Hospitals Financial Assistance:** - **Patient Financial Services Department:** For assistance, call 626-574-3594 (available 8 a.m. - 4:30 p.m.). - **USC Financial Aid Office:** For general inquiries, call (213) 740-4444 or visit the USC Financial Aid website. - **Student Health Insurance/Billing:** Contact the Student Health Insurance Office at 213-821-1550 or 213-740-9355 (WELL). - **USC Health Plans:** For information, call (213) 740-0035 or email healthplans@usc.edu.
What insurance does University of Southern California accept?
The University of Southern California (USC) offers comprehensive insurance options: - USC PPO includes three coverage tiers: Keck Medicine of USC providers, nationwide and worldwide Anthem providers, and non-network provider coverage. - USC Arcadia Hospital accepts most health care insurance plans. For details, contact Patient Financial Services. - USC Senior Care, a supplemental Medicare plan for University retirees, allows access to any doctor nationwide that accepts Medicare, with special benefits for services from Keck Medicine of USC physicians and affiliated hospitals. - USC mandates health insurance for all students, providing the USC SHIP/Aetna plan with vision care through EyeMed and a separate dental plan. UCLA Health accepts Medicare, most HMO, and PPO insurance plans.
What awards or recognition has University of Southern California received?
The University of Southern California (USC) and Children's Hospital Los Angeles (CHLA) have been awarded a $40 million gift from the Alfred E. Mann Charities. This generous donation will enhance research and innovation in biomedical engineering, supporting education, scholarships, and the creation of medical inventions at the USC Alfred E. Mann Institute. Furthermore, the establishment of the USC Alfred E. Mann-CHLA Joint Research Fund aims to advance biomedical research and innovation, specifically targeting improvements in pediatric care.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.